Gilead Sciences Releases Patent on Generic PrEP Treatment One Year Early
Gilead Sciences will release the patent of a generic version of an HIV prevention treatment one year earlier than expected to only one pharmaceutical company, reported Filter Magazine. The pharmaceutical com...